Logo image of LCID

LUCID GROUP INC (LCID) Stock Fundamental Analysis

NASDAQ:LCID - Nasdaq - US5494981039 - Common Stock

2.86  -0.21 (-6.84%)

After market: 2.8697 +0.01 (+0.34%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LCID. LCID was compared to 42 industry peers in the Automobiles industry. LCID scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LCID is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LCID had negative earnings in the past year.
LCID had a negative operating cash flow in the past year.
LCID had negative earnings in each of the past 5 years.
In the past 5 years LCID always reported negative operating cash flow.
LCID Yearly Net Income VS EBIT VS OCF VS FCFLCID Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -1B -2B -3B -4B

1.2 Ratios

The Return On Assets of LCID (-36.26%) is worse than 67.50% of its industry peers.
LCID has a worse Return On Equity (-82.23%) than 62.50% of its industry peers.
Industry RankSector Rank
ROA -36.26%
ROE -82.23%
ROIC N/A
ROA(3y)-41.98%
ROA(5y)-44.54%
ROE(3y)-79.52%
ROE(5y)-71.61%
ROIC(3y)N/A
ROIC(5y)N/A
LCID Yearly ROA, ROE, ROICLCID Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LCID so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LCID Yearly Profit, Operating, Gross MarginsLCID Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -5K -10K -15K

More info and screens

4

2. Health

2.1 Basic Checks

LCID does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LCID has been increased compared to 1 year ago.
LCID has a better debt/assets ratio than last year.
LCID Yearly Shares OutstandingLCID Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 500M 1B 1.5B 2B
LCID Yearly Total Debt VS Total AssetsLCID Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -1.54, we must say that LCID is in the distress zone and has some risk of bankruptcy.
LCID has a Altman-Z score (-1.54) which is in line with its industry peers.
LCID has a Debt/Equity ratio of 0.57. This is a neutral value indicating LCID is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.57, LCID perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z -1.54
ROIC/WACCN/A
WACC11.19%
LCID Yearly LT Debt VS Equity VS FCFLCID Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 2B -2B 4B

2.3 Liquidity

LCID has a Current Ratio of 3.71. This indicates that LCID is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LCID (3.71) is better than 92.50% of its industry peers.
LCID has a Quick Ratio of 3.26. This indicates that LCID is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.26, LCID belongs to the best of the industry, outperforming 92.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.71
Quick Ratio 3.26
LCID Yearly Current Assets VS Current LiabilitesLCID Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

6

3. Growth

3.1 Past

LCID shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.52%, which is quite impressive.
Looking at the last year, LCID shows a small growth in Revenue. The Revenue has grown by 4.98% in the last year.
The Revenue has been growing by 430.99% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)24.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.68%
Revenue 1Y (TTM)4.98%
Revenue growth 3Y430.99%
Revenue growth 5YN/A
Sales Q2Q%45.15%

3.2 Future

Based on estimates for the next years, LCID will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.73% on average per year.
Based on estimates for the next years, LCID will show a very strong growth in Revenue. The Revenue will grow by 62.30% on average per year.
EPS Next Y18.83%
EPS Next 2Y14.92%
EPS Next 3Y12.54%
EPS Next 5Y12.73%
Revenue Next Year24.15%
Revenue Next 2Y51.3%
Revenue Next 3Y66.3%
Revenue Next 5Y62.3%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LCID Yearly Revenue VS EstimatesLCID Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
LCID Yearly EPS VS EstimatesLCID Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -0.5 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LCID. In the last year negative earnings were reported.
Also next year LCID is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LCID Price Earnings VS Forward Price EarningsLCID Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LCID Per share dataLCID EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

LCID's earnings are expected to grow with 12.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.92%
EPS Next 3Y12.54%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LCID!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUCID GROUP INC

NASDAQ:LCID (1/21/2025, 6:52:48 PM)

After market: 2.8697 +0.01 (+0.34%)

2.86

-0.21 (-6.84%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners71.44%
Inst Owner Change0.02%
Ins Owners1.03%
Ins Owner Change0.37%
Market Cap8.61B
Analysts51.58
Price Target2.93 (2.45%)
Short Float %7.44%
Short Ratio2.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.04%
Min EPS beat(2)-7.42%
Max EPS beat(2)9.5%
EPS beat(4)2
Avg EPS beat(4)-3.69%
Min EPS beat(4)-18.24%
Max EPS beat(4)9.5%
EPS beat(8)4
Avg EPS beat(8)-2.9%
EPS beat(12)7
Avg EPS beat(12)2.73%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-0.94%
Max Revenue beat(2)2.39%
Revenue beat(4)2
Avg Revenue beat(4)-1.26%
Min Revenue beat(4)-14.35%
Max Revenue beat(4)7.87%
Revenue beat(8)2
Avg Revenue beat(8)-11.71%
Revenue beat(12)3
Avg Revenue beat(12)-13.35%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.1%
EPS NY rev (1m)0%
EPS NY rev (3m)2.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.91%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)1.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.79
P/FCF N/A
P/OCF N/A
P/B 2.3
P/tB 2.3
EV/EBITDA N/A
EPS(TTM)-1.17
EYN/A
EPS(NY)-0.96
Fwd EYN/A
FCF(TTM)-0.94
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS0.24
BVpS1.24
TBVpS1.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.26%
ROE -82.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-41.98%
ROA(5y)-44.54%
ROE(3y)-79.52%
ROE(5y)-71.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 317.97%
Cap/Sales 118.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.71
Quick Ratio 3.26
Altman-Z -1.54
F-Score4
WACC11.19%
ROIC/WACCN/A
Cap/Depr(3y)545.2%
Cap/Depr(5y)1769.66%
Cap/Sales(3y)627.8%
Cap/Sales(5y)3142.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.68%
EPS Next Y18.83%
EPS Next 2Y14.92%
EPS Next 3Y12.54%
EPS Next 5Y12.73%
Revenue 1Y (TTM)4.98%
Revenue growth 3Y430.99%
Revenue growth 5YN/A
Sales Q2Q%45.15%
Revenue Next Year24.15%
Revenue Next 2Y51.3%
Revenue Next 3Y66.3%
Revenue Next 5Y62.3%
EBIT growth 1Y2.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.28%
EBIT Next 3Y16.61%
EBIT Next 5Y13.47%
FCF growth 1Y-1.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.73%
OCF growth 3YN/A
OCF growth 5YN/A